Mass spectrometry-based proteomics is a sophisticated identification tool specializing in
portraying protein dynamics at a molecular level. Proteomics provides biologists with a …

Cardiomyopathy is a prevalent cardiovascular disease that affects individuals of all ages
and can lead to life-threatening heart failure. Despite its variety in types, each with distinct …

Heart failure with preserved ejection fraction (HFpEF) is a mortal clinical syndrome without
effective therapies. Empagliflozin (EMPA) improves cardiovascular outcomes in HFpEF …

Heart failure (HF) caused by structural or functional cardiac abnormalities is a significant
cause of morbidity and mortality worldwide. While HF with reduced ejection fraction (HErEF) …

Heart failure with preserved ejection fraction (HFpEF) is increasingly common but its
pathogenesis is poorly understood. The ability to assess genetic and pharmacologic …

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with
various phenotypes, and obesity is one of the most common and clinically relevant …

Heart disease remains a leading cause of death in North America and worldwide. Despite
advances in therapies, the chronic nature of cardiovascular diseases ultimately results in …

Zoapatle, a native plant utilized for centuries in traditional Mexican medicine, is abundantly
found in Mesoamerica and northern South America. Pleiotropic effects of this genus have …

Recognizing the fact that isolated left ventricular (LV) diastolic dysfunction (DD) underlies
approximately 50% of all heart failure cases requires a deep understanding of its principal …

Background: Post-infarction chronic heart failure is the most common type of heart failure.
Patients with chronic heart failure show elevated morbidity and mortality with limited …